Month: July 2026
Cooley Market Talks – The Technology Outlook: H2 2026 and Beyond
Public capital markets are back in the strategic conversation for technology companies. The change is not limited to better IPO windows. Companies have a broader set of financing choices, investors are showing an appetite for large growth stories, and a credible public market path can give boards more leverage as […]
FTC Secures Record $12 Million Penalty for HSR Violation
On July 13, 2026, the Federal Trade Commission (FTC) announced that Edwards Lifesciences and Genesis MedTech Group agreed to pay a combined civil penalty of $12 million to settle allegations that they intentionally structured Edwards’ acquisition of JC Medical, a subsidiary of Genesis, to avoid premerger reporting requirements under the Hart-Scott-Rodino (HSR) […]